Dorsey Wright & Associates
- SEC CIK
- 0001376772
- Latest filing
- Aug 6, 2026
HBIO holding history
Harvard Bioscience Inc in every 13F filed by Dorsey Wright & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HBIO overviewAll 13F holders of HBIOFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −3,962−100.0% | Sold out | Holders |
| Q3 2023 | 3,962 | $17.0K | <0.1% | −137−3.3% | Reduced | Holders |
| Q2 2023 | 4,099 | $22.5K | <0.1% | +4,099 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −7,740−100.0% | Sold out | Holders |
| Q4 2021 | 7,740 | $55.0K | <0.1% | +1,048+15.7% | Added | Holders |
| Q3 2021 | 6,692 | $47.0K | <0.1% | +524+8.5% | Added | Holders |
| Q2 2021 | 6,168 | $51.0K | <0.1% | +6,168 | New | Holders |